{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:18:17Z","timestamp":1794266297067,"version":"4.9.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Uniwersytet Medyczny im. Piast\u00f3w Slaskich we Wroclawiu","doi-asserted-by":"publisher","award":["ST-971"],"award-info":[{"award-number":["ST-971"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.schres.2017.04.015","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T02:31:45Z","timestamp":1492137105000},"page":"16-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"special_numbering":"C","title":["Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review"],"prefix":"10.1016","volume":"192","author":[{"given":"B\u0142a\u017cej","family":"Misiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Sta\u0144czykiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Kotowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz K.","family":"Rybakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Samochowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Frydecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.04.015_bb0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fpsyt.2013.00182","article-title":"A systematic review of cognitive function in first-episode psychosis, including a discussion on childhood trauma, stress, and inflammation","volume":"4","author":"Aas","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2017.04.015_bb0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbi.2014.02.015","article-title":"Interleukin 18 activates MAPKs and STAT3 but not NF-kappaB in hippocampal HT-22 cells","volume":"40","author":"Alboni","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.schres.2017.04.015_bb0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1586\/17512433.2016.1095086","article-title":"Anti-inflammatory strategies in the treatment of schizophrenia","volume":"9","author":"Andrade","year":"2016","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.schres.2017.04.015_bb0020","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jpsychires.2013.05.032","article-title":"Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia","volume":"47","author":"Asevedo","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2017.04.015_bb0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.physbeh.2014.02.032","article-title":"Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia","volume":"129","author":"Asevedo","year":"2014","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/cn300186b","article-title":"A dialogue between the immune system and brain, spoken in the language of serotonin","volume":"4","author":"Baganz","year":"2013","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/JBCPP.1995.6.1.61","article-title":"Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients","volume":"6","author":"Barak","year":"1995","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.04.015_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jad.2011.12.034","article-title":"Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers","volume":"137","author":"Barbosa","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0045","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1017\/S135561770410307X","article-title":"The d2 test of attention: construct validity and extensions in scoring techniques","volume":"10","author":"Bates","year":"2004","journal-title":"J. Int. Neuropsychol. Soc.: JINS"},{"key":"10.1016\/j.schres.2017.04.015_bb0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpsychires.2014.04.017","article-title":"Inflammatory mediators of cognitive impairment in bipolar disorder","volume":"56","author":"Bauer","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2017.04.015_bb0055","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2015.67","article-title":"Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-alpha","volume":"21","author":"Baumeister","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2017.04.015_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2016.05.047","article-title":"Inflammatory cytokines influence measures of white matter integrity in bipolar disorder","volume":"202","author":"Benedetti","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.schres.2017.04.015_bb0065","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1046\/j.1471-4159.2001.00628.x","article-title":"Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex","volume":"79","author":"Bezchlibnyk","year":"2001","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/schbul\/18.3.437","article-title":"Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration","volume":"18","author":"Bilder","year":"1992","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.schres.2017.04.015_bb0075","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/schbul\/sbu198","article-title":"Meta-analysis of cognitive impairment in first-episode bipolar disorder: comparison with first-episode schizophrenia and healthy controls","volume":"41","author":"Bora","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tins.2014.12.006","article-title":"The role of inflammatory cytokines as key modulators of neurogenesis","volume":"38","author":"Borsini","year":"2015","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.schres.2017.04.015_bb0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/1570159X13666150630171433","article-title":"The involvement of TNF-alpha in cognitive dysfunction associated with major depressive disorder: an opportunity for domain specific treatments","volume":"13","author":"Bortolato","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.schres.2017.04.015_bb0090","first-page":"3111","article-title":"Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses","volume":"11","author":"Bortolato","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"5","key":"10.1016\/j.schres.2017.04.015_bb0095","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/schbul\/sbw029","article-title":"Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset","volume":"42","author":"Bulzacka","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000353613","article-title":"The link between high-sensitivity C-reactive protein and orbitofrontal cortex in euthymic bipolar disorder","volume":"68","author":"Chung","year":"2013","journal-title":"Neuropsychobiology"},{"issue":"8","key":"10.1016\/j.schres.2017.04.015_bb0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S1092852900020393","article-title":"Cytokine polymorphisms in the pathophysiology of mood disorders","volume":"14","author":"Clerici","year":"2009","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.schres.2017.04.015_bb2000","series-title":"Cochrane reviewers' handbook. Version 4.2.1.","article-title":"Collaboration","author":"Cochrane","year":"2003"},{"issue":"2","key":"10.1016\/j.schres.2017.04.015_bb0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4088\/JCP.14r09007","article-title":"C-reactive protein alterations in bipolar disorder: a meta-analysis","volume":"76","author":"Dargel","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.schres.2017.04.015_bb0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1348\/014466599162881","article-title":"The doors and people memory test: validation of norms and some new correction formulae","volume":"38","author":"Davis","year":"1999","journal-title":"Br. J. Clin. Psychol."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.04.015_bb0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2006.08.015","article-title":"The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia","volume":"89","author":"Dickerson","year":"2007","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.04.015_bb0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.schres.2007.03.022","article-title":"C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia","volume":"93","author":"Dickerson","year":"2007","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.schres.2011.10.003","article-title":"Additive effects of elevated C-reactive protein and exposure to herpes simplex virus type 1 on cognitive impairment in individuals with schizophrenia","volume":"134","author":"Dickerson","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2017.04.015_bb0135","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jad.2013.04.039","article-title":"Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder","volume":"150","author":"Dickerson","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.04.015_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.schres.2014.04.019","article-title":"A longitudinal study of cognitive functioning in schizophrenia: clinical and biological predictors","volume":"156","author":"Dickerson","year":"2014","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2017.04.015_bb0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hup.2301","article-title":"Levels of TNF-alpha, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder","volume":"28","author":"Doganavsargil-Baysal","year":"2013","journal-title":"Hum. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.schres.2017.04.015_bb0150","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a Frontal Assessment Battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02214761","article-title":"The California verbal learning test: psychometric characteristics and clinical application","volume":"5","author":"Elwood","year":"1995","journal-title":"Neuropsychol. Rev."},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0160","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.schres.2013.07.029","article-title":"A systematic, quantitative review of blood autoantibodies in schizophrenia","volume":"150","author":"Ezeoke","year":"2013","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","article-title":"Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise","volume":"33","author":"Felger","year":"2012","journal-title":"Front. Neuroendocrinol."},{"issue":"4","key":"10.1016\/j.schres.2017.04.015_bb0170","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mp.2015.87","article-title":"C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications","volume":"21","author":"Fernandes","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2017.04.015_bb0175","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/mp.2015.90","article-title":"Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume","volume":"21","author":"Fillman","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2017.04.015_bb0185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fnbeh.2014.00416","article-title":"Impairments of working memory in schizophrenia and bipolar disorder: the effect of history of psychotic symptoms and different aspects of cognitive task demands","volume":"8","author":"Frydecka","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"6","key":"10.1016\/j.schres.2017.04.015_bb0190","first-page":"449","article-title":"Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation","volume":"265","author":"Frydecka","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2017.04.015_bb0195","first-page":"575","article-title":"Sex differences in TGFB-beta signaling with respect to age of onset and cognitive functioning in schizophrenia","volume":"11","author":"Frydecka","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"12","key":"10.1016\/j.schres.2017.04.015_bb0200","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"8\u201310","key":"10.1016\/j.schres.2017.04.015_bb0205","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.psyneuen.2007.09.004","article-title":"A dual role for interleukin-1 in hippocampal-dependent memory processes","volume":"32","author":"Goshen","year":"2007","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"10.1016\/j.schres.2017.04.015_bb0210","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.mp.4002055","article-title":"Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression","volume":"13","author":"Goshen","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.04.015_bb0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.acn.2005.12.006","article-title":"The validity of the letter memory test as a measure of memory malingering: robustness to coaching","volume":"21","author":"Greub","year":"2006","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.schres.2017.04.015_bb0220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2015.03.038","article-title":"Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels","volume":"179","author":"Hamdani","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.schres.2017.04.015_bb0225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2466\/pr0.2002.90.2.355","article-title":"Concurrent validity of the Wechsler abbreviated scale of intelligence and the Kaufman brief intelligence test among psychiatric inpatients","volume":"90","author":"Hays","year":"2002","journal-title":"Psychol. Rep."},{"issue":"5","key":"10.1016\/j.schres.2017.04.015_bb0230","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/13803390490918444","article-title":"Test review: Delis-Kaplan executive function system","volume":"27","author":"Homack","year":"2005","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.04.015_bb0235","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.schres.2015.04.004","article-title":"Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls","volume":"165","author":"Hope","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.04.015_bb0240","first-page":"1","article-title":"Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy","author":"Hori","year":"2016","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2017.04.015_bb0245","article-title":"Meta-analysis of cytokine and chemokine genes in schizophrenia","author":"Hudson","year":"2016","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0250","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jpsychires.2012.11.015","article-title":"A systematic review of studies of depression prevalence in university students","volume":"47","author":"Ibrahim","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"89","key":"10.1016\/j.schres.2017.04.015_bb0255","first-page":"81","article-title":"Mental set and shift","volume":"14","author":"Jersild","year":"1927","journal-title":"Arch. Psychol."},{"key":"10.1016\/j.schres.2017.04.015_bb0260","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12888-016-0769-x","article-title":"The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis","volume":"16","author":"Johnsen","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2017.04.015_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2015.08.019","article-title":"Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups","author":"Joseph","year":"2015","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2017.04.015_bb0270","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1440-1819.2007.01725.x","article-title":"Brief assessment of cognition in schizophrenia: validation of the Japanese version","volume":"61","author":"Kaneda","year":"2007","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2017.04.015_bb0275","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbi.2016.02.005","article-title":"Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder","volume":"54","author":"Karpinski","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.schres.2017.04.015_bb0280","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.04.015_bb0285","article-title":"Manual Demenz test - Wrotproduktion (\u201cSupermarktaufgabe\u201d)","volume":"10","author":"Kessler","year":"1988","journal-title":"Dementznornmen."},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0290","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/schbul\/sbp023","article-title":"Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections?","volume":"35","author":"Kinney","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2017.04.015_bb0295","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1080\/01688639408402697","article-title":"Tower of London procedure: a standard method and developmental data","volume":"16","author":"Krikorian","year":"1994","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.schres.2017.04.015_bb0300","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fpsyt.2014.00011","article-title":"A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation","volume":"5","author":"Kroken","year":"2014","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2017.04.015_bb0305","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1037\/a0016277","article-title":"A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state","volume":"23","author":"Kurtz","year":"2009","journal-title":"Neuropsychology"},{"issue":"4","key":"10.1016\/j.schres.2017.04.015_bb0310","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/bph.13364","article-title":"Microglial activation and progressive brain changes in schizophrenia","volume":"173","author":"Laskaris","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"17\u201318","key":"10.1016\/j.schres.2017.04.015_bb0315","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.lfs.2008.02.010","article-title":"Chronic mild stress impairs cognition in mice: from brain homeostasis to behavior","volume":"82","author":"Li","year":"2008","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0320","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.psychres.2011.05.038","article-title":"Cross-cultural comparisons on Wisconsin card sorting test performance in euthymic patients with bipolar disorder","volume":"189","author":"Liu","year":"2011","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.schres.2017.04.015_bb0325","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/gps.4048","article-title":"The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder","volume":"29","author":"Lotrich","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0330","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00213-014-3650-y","article-title":"Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition","volume":"232","author":"Lv","year":"2015","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.schres.2017.04.015_bb0335","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000334525","article-title":"The diagnostic value of controlled oral word association test-FAS and category fluency in single-domain amnestic mild cognitive impairment","volume":"32","author":"Malek-Ahmadi","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.schres.2017.04.015_bb0340","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jad.2015.12.055","article-title":"The role of environmental exposures as risk factors for bipolar disorder: a systematic review of longitudinal studies","volume":"193","author":"Marangoni","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.04.015_bb0345","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2012.03.004","article-title":"Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes","volume":"137","author":"Martinez-Cengotitabengoa","year":"2012","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0350","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neubiorev.2008.10.005","article-title":"Evidence for a cytokine model of cognitive function","volume":"33","author":"McAfoose","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0355","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/npp.2010.193","article-title":"Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia","volume":"36","author":"McClay","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2017.04.015_bb0360","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbi.2016.09.008","article-title":"Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: a prospective birth cohort study","volume":"59","author":"Metcalf","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0365","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.schres.2015.03.018","article-title":"Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia","volume":"165","author":"Micoulaud-Franchi","year":"2015","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2017.04.015_bb0370","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2017.04.015_bb0375","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.biopsych.2012.09.007","article-title":"Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects","volume":"73","author":"Miller","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2017.04.015_bb0380","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neubiorev.2017.02.015","article-title":"Toward a unified theory of childhood trauma and psychosis: a comprehensive review of epidemiological, clinical, neuropsychological and biological findings","volume":"75","author":"Misiak","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.schres.2017.04.015_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"Suppl. 6","key":"10.1016\/j.schres.2017.04.015_bb0390","first-page":"23","article-title":"Bipolar disorder and schizophrenia: distinct illnesses or a continuum?","volume":"64","author":"Moller","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.04.015_bb0395","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1515\/revneuro-2015-0060","article-title":"Cognitive function in schizophrenia: conflicting findings and future directions","volume":"27","author":"Moustafa","year":"2016","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.schres.2017.04.015_bb0400","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fnins.2015.00372","article-title":"The role of inflammation in schizophrenia","volume":"9","author":"Muller","year":"2015","journal-title":"Front. Neurosci."},{"issue":"9","key":"10.1016\/j.schres.2017.04.015_bb0405","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0410","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2014.04.041","article-title":"Neuroinflammation and white matter pathology in schizophrenia: systematic review","volume":"161","author":"Najjar","year":"2015","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2017.04.015_bb0415","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0010-9452(78)80049-5","article-title":"Dementia: the estimation of premorbid intelligence levels using the new adult reading test","volume":"14","author":"Nelson","year":"1978","journal-title":"Cortex"},{"issue":"2","key":"10.1016\/j.schres.2017.04.015_bb0420","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity","volume":"165","author":"Nuechterlein","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.04.015_bb0425","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.schres.2014.05.001","article-title":"Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder","volume":"157","author":"Pearlman","year":"2014","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2017.04.015_bb0430","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1080\/13854046.2012.713513","article-title":"The Stroop task: comparison between the original paradigm and computerized versions in children and adults","volume":"26","author":"Penner","year":"2012","journal-title":"Clin. Neuropsychol."},{"issue":"8","key":"10.1016\/j.schres.2017.04.015_bb0435","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0440","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","article-title":"The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity","volume":"20","author":"Randolph","year":"1998","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"4","key":"10.1016\/j.schres.2017.04.015_bb0445","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/mp.2009.47","article-title":"Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients","volume":"15","author":"Rao","year":"2010","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0450","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.schres.2013.02.017","article-title":"Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients","volume":"147","author":"Rao","year":"2013","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0455","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/arclin\/10.1.21","article-title":"Stability of performance on the Hopkins verbal learning test","volume":"10","author":"Rasmusson","year":"1995","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"5","key":"10.1016\/j.schres.2017.04.015_bb0460","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1037\/h0044509","article-title":"The relation of the trail making test to organic brain damage","volume":"19","author":"Reitan","year":"1955","journal-title":"J. Consult. Psychol."},{"key":"10.1016\/j.schres.2017.04.015_bb0465","series-title":"The Clinical Examination in Psychology","author":"Rey","year":"1964"},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0470","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1570159X1203140511160832","article-title":"Evidence for an immune role on cognition in schizophrenia: a systematic review","volume":"12","author":"Ribeiro-Santos","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.schres.2017.04.015_bb0475","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1037\/0096-3445.124.2.207","article-title":"Costs of a predictable switch between simple cognitive tasks","volume":"124","author":"Rogers","year":"1995","journal-title":"J. Exp. Psychol. General"},{"key":"10.1016\/j.schres.2017.04.015_bb0480","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jad.2015.08.058","article-title":"Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications","volume":"188","author":"Rosenblat","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0485","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1037\/0882-7974.6.1.118","article-title":"Effects of adult age on structural and operational capacities in working memory","volume":"6","author":"Salthouse","year":"1991","journal-title":"Psychol. Aging"},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0490","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jpsychires.2012.12.001","article-title":"Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder","volume":"47","author":"Sasayama","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.schres.2017.04.015_bb0495","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1017\/S1138741600002158","article-title":"Validity evidence for the reading competence test of words and non-words","volume":"12","author":"Seabra","year":"2009","journal-title":"Sp. J. Psychol."},{"key":"10.1016\/j.schres.2017.04.015_bb0500","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fpsyg.2014.00772","article-title":"What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults","volume":"5","author":"Shao","year":"2014","journal-title":"Front. Psychol."},{"issue":"8","key":"10.1016\/j.schres.2017.04.015_bb0505","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.eurpsy.2015.08.005","article-title":"Long-term trajectories of cognitive deficits in schizophrenia: a critical overview","volume":"30","author":"Shmukler","year":"2015","journal-title":"Eur. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.04.015_bb0510","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/09540260902962149","article-title":"Cognitive functioning in patients with affective disorders and schizophrenia: a meta-analysis","volume":"21","author":"Stefanopoulou","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.04.015_bb0515","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2015.10.038","article-title":"Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia","volume":"169","author":"Tan","year":"2015","journal-title":"Schizophr. Res."},{"issue":"26","key":"10.1016\/j.schres.2017.04.015_bb0520","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1073\/pnas.94.26.14792","article-title":"Role of left inferior prefrontal cortex in retrieval of semantic knowledge: a reevaluation","volume":"94","author":"Thompson-Schill","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.04.015_bb0525","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.schres.2017.04.015_bb0530","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/mp.2016.90","article-title":"Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review","volume":"21","author":"Trepanier","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2017.04.015_bb0535","first-page":"275","article-title":"C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia","volume":"22","author":"Vuksan-Cusa","year":"2010","journal-title":"Psychiatr. Danub."},{"issue":"5","key":"10.1016\/j.schres.2017.04.015_bb0540","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/08039488.2012.745601","article-title":"Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia","volume":"67","author":"Vuksan-Cusa","year":"2013","journal-title":"Nord. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.04.015_bb0545","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.schres.2012.01.031","article-title":"Searching for a consensus five-factor model of the positive and negative syndrome scale for schizophrenia","volume":"137","author":"Wallwork","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2017.04.015_bb0550","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0197-0186(98)00016-3","article-title":"Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism","volume":"33","author":"Wang","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.schres.2017.04.015_bb0555","series-title":"Wechsler Memory Scale","author":"Wechsler","year":"1997"},{"key":"10.1016\/j.schres.2017.04.015_bb0560","series-title":"Weschsler Adult Intelligence Scale-III","author":"Wechsler","year":"1997"},{"issue":"3","key":"10.1016\/j.schres.2017.04.015_bb0565","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/09084282.2010.499787","article-title":"Validity of the Wechsler Test of Adult Reading (WTAR): effort considered in a clinical sample of U.S. military veterans","volume":"17","author":"Whitney","year":"2010","journal-title":"Appl. Neuropsychol."},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0570","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3810\/pgm.2011.01.2252","article-title":"C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians","volume":"123","author":"Windgassen","year":"2011","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.schres.2017.04.015_bb0575","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpsychires.2016.01.013","article-title":"Altered interleukin-18 levels are associated with cognitive impairment in chronic schizophrenia","volume":"76","author":"Wu","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.schres.2017.04.015_bb0580","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2014.03.024","article-title":"Decreased interleukin-10 serum levels in first-episode drug-naive schizophrenia: relationship to psychopathology","volume":"156","author":"Xiu","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.04.015_bb0585","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbi.2016.03.005","article-title":"Contribution of IL-10 and its \u2212592A\/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia","volume":"57","author":"Xiu","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2017.04.015_bb0590","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/001872086300500102","article-title":"Keeping track of several things at once","volume":"5","author":"Yntema","year":"1963","journal-title":"Hum. Factors"},{"issue":"1\u20132","key":"10.1016\/j.schres.2017.04.015_bb0595","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-8993(94)90006-X","article-title":"Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6","volume":"643","author":"Zalcman","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2017.04.015_bb0600","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbi.2013.03.001","article-title":"Interleukin 18 and cognitive impairment in first episode and drug naive schizophrenia versus healthy controls","volume":"32","author":"Zhang","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2017.04.015_bb0605","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbi.2015.09.014","article-title":"Interaction of BDNF with cytokines in chronic schizophrenia","volume":"51","author":"Zhang","year":"2016","journal-title":"Brain Behav. Immun."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417302025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417302025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:27:10Z","timestamp":1760297230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417302025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":122,"alternative-id":["S0920996417302025"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.04.015","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}